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ABSTRACT
Oligodendrocytes generate myelin in the vertebrate
central nervous system and thus ensure rapid prop-
agation of neuronal activity. Their development is
controlled by a network of transcription factors that
function as determinants of cell identity or as tem-
porally restricted stage-specific regulators. The con-
tinuously expressed Sox10 and Myrf, a factor in-
duced during late development, are particularly im-
portant for terminal differentiation. How these factors
function together mechanistically and influence each
other, is not well understood. Here we show that Myrf
not only cooperates with Sox10 during the induc-
tion of genes required for differentiation and myelin
formation. Myrf also inhibits the activity of Sox10
on genes that are essential during earlier phases of
oligodendroglial development. By characterization of
the exact DNA-binding requirements of Myrf, we fur-
thermore show that cooperative activation is a con-
sequence of joint binding of Sox10 and Myrf to the
same regulatory regions. In contrast, inhibition of
Sox10-dependent gene activation occurs on genes
that lack Myrf binding sites and likely involves phys-
ical interaction between Myrf and Sox10 followed by
sequestration. These two opposite activities allow
Myrf to redirect Sox10 from genes that it activates in
oligodendrocyte precursor cells to genes that need
to be induced during terminal differentiation.
INTRODUCTION
In the vertebrate central nervous system (CNS),
oligodendrocyte-dependent myelination ensures rapid
saltatory conduction along axons. If myelin is defective or
damaged, severe cognitive and motor disabilities result.
Oligodendrocytes acquire their ability to form myelin
sheaths around axonal segments during terminal differ-
entiation from committed oligodendrocyte precursor cells
(OPCs).
This process is regulated by a complex regulatory net-
work that is constructed around central transcriptional reg-
ulators and additionally includes chromatin modifying pro-
teins and regulatory RNAs (1–4). Among transcriptional
regulators, the bHLH domain containing Olig2 and the
HMG domain containing Sox10 are particularly important
as they are present at all times of oligodendroglial devel-
opment. They simultaneously determine oligodendroglial
identity and stage-specific expression patterns. As a conse-
quence, expression of some target genes will be regulated by
these factors at all times, whereas others will be under their
control only during specific developmental phases (5).
Many genes that are activated during terminal differenti-
ation in oligodendrocytes and required formyelination have
been identified as direct target genes of Sox10 (6). It has
furthermore been shown that Sox10 is helped in its func-
tion byMyelinGeneRegulatory Factor (Myrf), a transcrip-
tion factor that becomes expressed shortly before termi-
nal differentiation and is itself a Sox10 target gene in these
cells (7,8). Myrf is a large protein with an immunoglobulin-
type Ndt80 domain for DNA-binding in its aminotermi-
nal region, an intramolecular chaperone domain (ICD) for
trimerization and autoproteolysis in the central portion and
a transmembrane-domain in its carboxyterminal part that
anchors the protein in the membrane of the endoplasmic
reticulum (ER) (9,10). Upon homotrimerization and auto-
proteolysis, the trimerized aminoterminal half is released,
enters the nucleus and supports Sox10 in the induction of
the myelination program.
In contrast to the large number of validated target genes
of Sox10 in differentiating oligodendrocytes, there are only
few known Sox10 target genes in OPCs. Some evidence has
been recently obtained forPdgfra andNG2/Cspg4 as poten-
tial targets (11,12). Pdgfra, in particular, is highly relevant as
it determines proliferation, survival and migration of OPCs
downstream of platelet derived growth factor (Pdgf).
Considering the existence of stage-specific target genes
for Sox10 during oligodendroglial development, mecha-
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nisms must be in place that temporally restrict Sox10 ac-
tivity on the corresponding regulatory regions and direct it
from one set of target genes to another. The selective occur-
rence of cooperating factors such as Myrf in differentiat-
ing oligodendrocytes represents one important mechanism
(8). Additionally, there is evidence that proteins in OPCs
such as Hes5 and SoxD factors prevent Sox10 from acti-
vating genes that it targets later during terminal differen-
tiation (13,14). However, no mechanism has yet been de-
scribed that explains the selective downregulation of those
Sox10 target genes that are expressed in OPCs and whose
expression needs to be extinguished in differentiating oligo-
dendrocytes.
To increase knowledge of Sox10 target genes inOPCs and
the mechanisms by which their expression is temporally re-
stricted, we combined results fromRNA-Seq andChIP-Seq
studies to define a large number of OPC-specific Sox10 tar-
get genes and then analyzed several of these target genes
to understand on a mechanistic level how their expression
is turned off in differentiating oligodendrocytes despite the
continued presence of Sox10. Our study identified Myrf as
a decisive factor that helps Sox10 to switch between its tar-
get genes. Our analyses also revealed hitherto unknown and
unexpected features of Myrf function.
MATERIALS AND METHODS
Cell culture
Primary oligodendroglial cells were obtained from newborn
Wistar rats of both sexes after growth in mixed glial cul-
tures by shake-off (15). Oligodendroglial cells were grown
on poly-ornithine substrate under proliferative conditions
in serum-free SATOmedium containingN2 supplement, 10
ng/ml Pdgf-AA and 10 ng/ml Fgf2. Differentiation was in-
duced by replacing the mitogens by 1% FCS (16). In some
experiments, oligodendroglial cells were retrovirally trans-
duced at amoiety of infection of 0.2 under proliferative con-
ditions.
Spontaneously immortalized rat OLN93 oligoden-
droglial cells (gift of C. Richter-Landsberg) (17), mouse
N2a neuroblastoma cells (obtained from ATCC, #CCL-
131) and human embryonic kidney 293 (HEK293) cells
(obtained fromATCC, #CRL-1573) were grown inDMEM
supplemented with 10% fetal calf serum (FCS). Of the cell
lines, only OLN93 cells were authenticated by PCR. None
was checked for mycoplasma contamination. N2a cells
were used for luciferase reporter assays (8), HEK293 cells
for preparation of protein extracts (18). Genome-editing of
OLN93 cells and characterization of resulting cell clones
has been described elsewhere in detail (19).
RNA-Seq and bioinformatic analysis
Total RNA was prepared from independent OLN93 cell
clones A and B that had undergone CRISPR/Cas9-
dependent genome editing to inactivate Sox10with different
guide RNAs and two control clones using the RNeasy Mi-
cro Kit (Qiagen). RNA samples were treated with DNase
I to remove contaminating DNA. Quality and purity of
samples were evaluated using an Agilent 2100 Bioanalyzer
(Agilent Technologies Germany). 100 ng total RNA were
used for library preparation (Ilumina Stranded mRNA
Kit). Approximately 52 million reads were generated per
library using an Illumina Hiseq 2500 platform sequencer
(NextGeneration SequencingCore Facility, FAUErlangen-
Nu¨rnberg) and mapped onto rat genome rn5 using STAR
(version 2.5.1.b). Unique mappings were detected using
HTSeq count based on ENSEMBLGene identifier Version
75. Statistical analysis was carried out usingDESeq2RVer-
sion 1.8.1. Gene expression values are deposited in GEO
under accession number GSE136659.
To identify direct Sox10 target genes in oligodendroglial
cells, genes were summarized in a list that were downregu-
lated in Sox10-negative OLN93 cells (≤–2-fold, P ≤ 0.05).
A second list was generated that contained all genes associ-
ated with CNS-specific Sox10 ChIP-Seq peaks (GSE64703)
(20) as determined by intersect (version 1.0.0). The two
gene lists were then compared using the Venn webtool
on the BEG homepage (http://bioinformatics.psb.ugent.
be/webtools/Venn/). The resulting 203 genes with Sox10-
dependent expression and nearby genomic Sox10 binding
site were defined as potential Sox10 target genes. Using lists
of genes with preferential expression in OPCs or differen-
tiating oligodendrocytes (21) and comparing them to the
203 genes using the Venn webtool, potential Sox10 target
genes were classified as enriched in OPCs or in differen-
tiating oligodendrocytes. Gene ontology (GO) analysis of
OPC-enriched direct Sox10 target genes was performed us-
ing the Gene Ontology enrichment, analysis and visualiza-
tion tool (http://cbl-gorilla.cs.technion.ac.il/) in combina-
tion with semantic clustering byREViGO (http://revigo.irb.
hr/) (22). The Integrative Genomics Viewer (IGV) was used
to visualize select ChIP-Seq peaks.
Plasmids and viral constructs
Regulatory regions from the Id4, Tgfb2,Wnt7a genes (650–
1000 bp, for localization, see Figure 1E–G and 2A) were
obtained by PCR from mouse genomic DNA and inserted
into the pTATAluc reporter plasmid (23). In case of the
pTATAluc reporter containing the Wnt7a regulatory re-
gion, an additional version was generated with inserted syn-
thetic Myrf binding site (c)3(c) (Figure 5A). The pTATAluc
plasmid was also used to place the Sox10 binding site C/C’
(23) in front of the -globin minimal promoter to generate
the dimluc reporter construct. Into the dimluc reporter po-
tential Myrf binding sites were additionally inserted (for se-
quences, see Figures 5A and 6A). Luciferase reporter plas-
mids with regulatory regions of the Pdgfra, Cspg4, Mag,
Aatk andMbp genes were as described before (8,12,19,24).
Site-directed mutagenesis of Myrf binding sites (see Figure
7A) was performed with the Q5® Site-Directed Mutagene-
sis Kit (New England Biolabs).
Myrf variants (see Figure 4A) were generated for this
study by PCR from a full-length mouse Myrf cDNA or
have already been described (25). They were inserted into
pCMV5 expression vectors. For MyrfC, an additional
version was generated with myc epitope at its aminoter-
minal end. pCMV5-based eukaryotic expression plasmids
for full-length Myrf, Sox6 and Sox10 were as reported
(8,14,18). Full-length Myrf and the MyrfC variant were
also inserted behind the chicken -actin (CAG) promoter
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into a retroviral CAG-IRES-GFP vector (26) to gener-
ate Myrf overexpressing retroviruses. Myrf expressing and
control retroviruses co-expressed GFP for visualization of
transduced cells.
Luciferase assays, extract preparation, electrophoreticmobil-
ity shift assays and protein interaction studies
For luciferase assays, N2a cells were transfected with 0.5 g
of luciferase reporter and 0.5 g of pCMV5-based expres-
sion plasmid per 3.5 cm plate using Superfect reagent (Qia-
gen). Overall amounts of plasmid in a particular experiment
were kept constant by adding empty pCMV5 where neces-
sary. Whole cell extracts were prepared 48 h after transfec-
tion by lysing cells in buffer containing 0.1% Triton X-100
and 2.5 mM ATP. Luciferase activities were determined af-
ter addition of luciferin substrate by chemiluminescence.
For preparation of protein extracts, HEK293 cells were
transfected on 10 cm plates with 10g of pCMV5-based ex-
pression plasmids using polyethylenimine. 48 h after trans-
fection, whole cell extracts were prepared by using 1% NP-
40 to initiate cell lysis and 400 mMNaCl to extract nuclear
proteins (27).
Whole cell extracts were used in electrophoretic mo-
bility shift assays (EMSA) or protein interaction stud-
ies. EMSA were performed with extracts and 32P-labeled
double-stranded oligonucleotides containing putativeMyrf
binding sites (for sequences, see Figures 5A and 6A, B).
Oligonucleotides were 33–41 bp in length. PolydIdC was
used as unspecific competitor at a final concentration of 0.1
g/l.
For co-immunoprecipitation experiments, HEK293 cell
extracts were incubated with rabbit antibodies against
Sox10 (home made) (28) or mouse monoclonals against
the myc epitope (Cell Signaling Technology clone 9B11,
1:10000 dilution) and protein A sepharose beads (GE
Healthcare). For GST-pulldown assays, whole cell extracts
of transfected HEK293 cells were incubated with bacteri-
ally expressed and purified GST or GST-Sox10 fusion pro-
teins bound to glutathione sepharose beads (27). After ex-
tensive washing, bead-boundmaterial was eluted by boiling
in 150 mM Tris–HCl, 6% SDS, 15% -mercaptoethanol,
30% glycerine, 0.3% bromophenol blue and compared to
the extracts used as input after size separation on 10% SDS-
polyacrylamide gels byWestern blotting. The following pri-
mary antibodies and detection reagents were used: rab-
bit anti-Sox10 antiserum (1:3000 dilution), mouse anti-myc
monoclonal (clone 9B11, 1:10 000 dilution) and horseradish
peroxidase coupled to protein A (Zymed, #10-1023, 1:3000
dilution). Detection was by chemiluminescence using ECL
reagent. Images ofWestern blots have been cropped for pre-
sentation.
Chromatin immunoprecipitation (ChIP)
Chromatin was prepared from rat oligodendroglial cells
cultured three days under differentiating conditions. Chro-
matin was cross-linked with 1% paraformaldehyde and
sheared to fragments of ∼200–400 bp in a Bioruptor (Di-
agenode) (27). After pre-clearing, chromatin was incubated
with rabbit antiserum against Myrf (home made, raised
against epitopes in the aminoterminal 386 amino acids)
(8), rabbit antiserum against Sox10 (28), or preimmune
sera before addition of protein A sepharose beads and pre-
cipitation. Crosslinks in precipitated chromatin were re-
versed and DNA was purified by proteinase K treatment,
phenol/chloroform extraction and ethanol precipitation.
Detection and quantification of the regulatory regions from
theTgfb2, Id4,Wnt7a,Mag,Aatk andMbp genes in precip-
itated DNA was by qPCR on a Bio-Rad CFX96 thermocy-
cler with each reaction performed in triplicates. The Ct
methodwas used to calculate the percent recovery of a given
DNA segment relative to the total input. After normaliza-
tion, the enrichment of chromatin in the various precipitates
over the input was determined. The sample with highest en-
richment in a specific experiment was set to 1 and all other
values were expressed relative to it.
The following primers were used for the detection of spe-
cific DNA regions: 5′-AAGTTCACATTCAGCGAAAC
G-3′ and 5′-GAGGACCCCTGAGTGAACAA- 3′ were
used to amplify the Tgfb2 regulatory region, 5′-GATAAA
GGAAGGCTTTCAGCAA-3′ and 5′-TTGGATGGTG
TGGTGCAG -3′ to amplify the Id4 regulatory region, 5′-
GAGCGAAAATCCAGGATGAA-3′ and 5′-GGATGG
ATGGGAAGTCCTTT-3′ to amplify the Wnt7a regula-
tory region, 5′- TTGGATGGTCTGGCTTCTG-3′and 5′-
CCCATCTTCTCCAGGAAGG-3′ to amplify the Mag
promoter region, 5′-AGCAAGAAGCTGGTGCTGAG-
3′and 5′- GAGTGGGTGCAGTGAGTCCT-3′ to amplify
the Aatk regulatory region, 5′-TTTGCTCACTCGAAGG
GACT-3′and 5′-TTAGGTCCTTCTGGGGACAGT-3′ to
amplify the Mbp regulatory region, and 5′-AGAGACTG
GTTGCCAGGAAG-3′ and 5′-GGTGGAGACAGACT
CGGAAC-3′ to amplify a negative control region (NCtrl).
Immunocytochemistry
Primary oligodendroglial cells were cultivated for two days
under proliferative conditions or for 6 days in differ-
entiation medium on cover slips before fixation in 4%
paraformaldehyde for 10 min. In some experiments, BrdU
was added at a final concentration of 4 mM to proliferation
medium 2 h before fixation. Cells on cover slips underwent
immunocytochemistry using the following primary anti-
bodies: rat anti-Mbp monoclonal (Bio-Rad, #MCA409S,
1:750 dilution), guinea pig anti-Sox10 antiserum (home
made, 1:5000 dilution) (29), rabbit anti-Id4 (Novus Biologi-
calsNBP2-56322, 1:50 dilution), mouse anti-Tgfb2 (Abcam
ab36495, 1:50 dilution) and mouse anti-Wnt7a (Santa Cruz
Biotechnology, E-9: sc-365665, 1:50 dilution). Secondary
antibodies were coupled to Cy3 (Dianova, 1:400 dilution),
Cy5 (Dianova, 1:400 dilution) or Alexa Fluor 488 (Molecu-
lar Probes, 1:0 000 dilution) fluorescent dyes. Incorporated
BrdU was visualized using rat anti-BrdU (Abcam ab6326,
1:200 dilution). Stainings were documented with a Leica
DMI6000 B inverted microscope (Leica) equipped with a
DFC 360FX camera (Leica).
Quantifications and statistical analysis
Results from independent experiments were treated as bi-
ological replicates. Sample size was n ≥ 3 for all molecu-
lar biology experiments and experiments using cell cultures
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Figure 1. Identification of OPC-specific target genes of Sox10. (A) Venn diagram identifying 203 candidate oligodendroglial target genes of Sox10 as the
overlap between genes differentially downregulated (≤–2-fold; P ≤ 0.05 according to GSE136659) in OLN93 cells following Sox10 inactivation (Sox10
OLN93) and genes exhibiting Sox10-binding in their vicinity in the CNS (20). (B, C) Venn diagram depicting the fraction of oligodendroglial target genes
of Sox10 with preferential expression in OPCs (B) or differentiating oligoendrocytes (C) as determined by analysing the stage-specific oligodendroglial
expression pattern (21) for the potential target genes. (D) List of 64 candidates for Sox10 target genes in OPCs. Genes with strongest downregulation in
Sox10-deficient OLN93 cells are at the top of the list. (E–G) IGV tracks showing Sox10 binding sites in the vicinity of the Tgfb2, Id4 and Wnt7a genes
according to ChIP-Seq studies (20). Exact chromosomal locations in the rat genome (rn6) are given below the tracks. Size bars correspond to 2 or 5 kb
as indicated. (H) Biological terms associated with OPC-specific Sox10 target genes according to gene ontology (GO) studies. Ranking was by enrichment
score. Genes listed under the terms were: Fgfr3, Dmd, Sox8, Tnik, Plxnd1, Olfm2, Adamts9, Ets1, Tgfb2, Marcks, Id4, Sox10, Nfatc2, Robo1, Has2,
Tmem100, Sox5, Tubb2b, Dag1 for positive regulation of cell differentiation; Sox8, Plxnd1, Ets1, Tgfb2, Wnt7a, Cdh13, Sox10, Apc2, Nfatc2, Robo1,
Mertk, Vav2, Sh3rf1, Tubb2b, Pstpip2 for cell motility and for locomotion; Sox8, Plxnd1, Ets1, Tgfb2, Wnt7a, Cdh13, Sox10, Apc2, Nfatc2, Robo1,
Kifc3, Mertk, Vav2, Sh3rf1, Tubb2b, Alcam, Dag1, Pstpip2 for movement of subcellular component; Ramp1, Fgfr3, Alk, Dmd, Plxnd1, Myo10, Prkar1b,
Adamts9, Tgfb2, Cdh13, Wnt7a, Ophn1, Apc2, Robo1, Il10rb, Vav2, Fgfrl1, Tmem100, Map3k1, Arhgap20, Irs2, Tnik, Sox8, Rin2, Spsb4, Lrp4, Shc4,
Nfatc2,Mertk, Rhpn1 for signal transduction; Tnik, Tnfrsf19, Tgfb2,Wnt7a, Sh3rf1,Map3k1 for regulation ofMAPK cascade; Has2,Mmp15, Adamts9,
Tgfb2, Gpm6b, Dag1, Col5a3 for extracellular matrix organization and for extracellular structure organization; Fgfr3, Dmd, Tnik, Sox8, Plxnd1, Lrp4,
Adamts9, Tgfb2, Cdh13, Wnt7a, Id4, Sox10, Ophn1, Robo1, Has2, Mertk, Fgfrl1, Map3k1, Dag1 for anatomical structure morphogenesis; Fgfr3, Id4,
Sox10, Dag1 for central nervous system myelination.
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as common for this kind of study. No data were excluded
from the analysis. GraphPad Prism6 (GraphPad software,
La Jolla, CA, USA) was used to determine whether differ-
ences in cell numbers, luciferase activities or immunoprecip-
itated DNA were statistically significant by one way Anova
with Bonferroni correction or two-tailed Student’s t tests
(*P ≤ 0.05; **P ≤ 0.01, ***P ≤ 0.001). Variance between
statistically compared groups was similar.
RESULTS
Sox10 activates a specific set of genes in OPCs
Wehave previously usedCRISPR/Cas9-dependent genome
editing to inactivate Sox10 in the immortalized rat oligo-
dendroglial cell line OLN93 (19). Here we performedRNA-
Seq on independent clones and compared the expression
profile to OLN93 control clones. Among the 594 genes that
were reproducibly downregulated ≥2-fold, 203 had previ-
ously been shown by ChIP-Seq to have closely associated
genomic Sox10 binding sites in oligodendroglial cells of
the CNS (20) (Figure 1A). By comparing the 203 genes
with published lists of genes enriched in OPCs or differ-
entiating oligodendrocytes from expression profiling data
(21), 64 were identified as being preferentially expressed in
OPCs relative to differentiating oligodendrocytes (Figure
1B), whereas 48 were found to exhibit higher expression
in differentiating oligodendrocytes than in OPCs (Figure
1C). Expression of the remaining 91 genes did not differ
substantially during oligodendrocyte differentiation. The
64 genes that have Sox10 binding regions near or within
them, depend on Sox10 for their expression and occur
preferentially in OPCs, are excellent candidates for OPC-
specific Sox10 target genes (Figure 1D–G). Gene ontology
studies indicated that the genes are associated with regu-
lation of cell differentiation, cell motility and extracellular
matrix/structure organization indicating that Sox10 may
influence lineage progression, migration and production of
secreted proteins in OPCs (Figure 1H).
OPC-specific and oligodendrocyte-specific Sox10 target
genes respond differentially to Myrf
Among the potential OPC-specific Sox10 target genes,
Tgfb2, Id4 and Wnt7a caught our attention (Figure 1D).
Tgfb2 has been previously shown to determine the migra-
tory properties of OPCs and their relationship with neurons
(30). Id4 helps OPCs to maintain their progenitor state and
interferes with oligodendrocyte differentiation (31–33), and
Wnt7a regulates the crosstalk of OPCswith vasculature and
neurons (34).
ChIP-Seq peaks for Sox10 in the vicinity of these genes
(Figure 1E–G) (20) were found to localize in evolutionary
conserved regions (ECRs) 23 kb downstream of the tran-
scription start site (TSS) of the Tgfb2 gene, 63 kb down-
stream of the TSS of the Id4 gene, and 10 kb downstream
of the TSS of theWnt7a gene in the mouse genome (Figure
2A).
The three identifiedECRswere inserted in luciferase plas-
mids to study their Sox10 responsiveness in reporter gene
assays. For comparison, plasmids containing the Pdgfra
promoter or an intronic enhancer of the Cspg4 gene were
also tested as these two regions represent the only other
regulatory regions known to be under control of Sox10
in OPCs (12,24). Additionally, we included luciferase plas-
mids containing the promoter of theMag gene, an intronic
enhancer of the Aatk gene or an upstream enhancer of
the Mbp gene as examples of well-characterized regula-
tory regions with Sox10-dependent activity in differentiat-
ing oligodendrocytes (Figure 2B) (8,19). WhereasMag and
Mbp code for structural myelin proteins, Aatk is the host
gene of miR-338, a differentiation promoting micro-RNA
in oligodendrocytes (35).
Following transfection in N2a cells, all newly identified
ECRs associated with OPC-expressed genes exhibited a ro-
bust Sox10-dependent activation in a range similar to the
other regulatory regions (compare Figure 2C–E to F–J).
No activation was observed when Sox10 was replaced by
Sox6 as another OPC-expressed Sox protein (Figure 2C–
J) (14). Regulatory regions from the Mag, Aatk and Mbp
genes furthermore responded to the joint presence of Myrf
and Sox10 in transfected cells with a substantially higher ac-
tivity. For theMag promoter, induction rates increased from
13 ± 3-fold in the presence of Sox10 to 39 ± 8-fold in the
presence of Sox10 andMyrf (Figure 2H). For the Aatk reg-
ulatory region, induction rates increased from 34± 8 fold to
53 ± 4 fold and for theMbp enhancer from 8 ± 1-fold to 14
± 2-fold (Figure 2I, J). As previously reported, the presence
of Myrf had little effect on its own (8), and Sox6 could not
substitute for Sox10 (Figure 2H–J). This confirms the spe-
cific synergistic activation of CNS myelin genes by Sox10
and Myrf (8,9).
In contrast, regulatory regions from the newly identified
OPC-specific Sox10 target genes exhibited lower activation
rates in the presence of Sox10 andMyrf than in the presence
of Sox10 alone with induction rates falling from 8 ± 2-fold
to 2± 1-fold forTgfb2, from10± 2-fold to 3± 1-fold for Id4
and from 19 ± 3-fold to 5 ± 1-fold forWnt7a (Figure 2C–
E). Intriguingly, a similar response towards Myrf was also
observed for the intronic enhancer of the Cspg4 gene and
the Pdgfra promoter. In case of the Cspg4 enhancer, Sox10-
dependent activation rates fell from 37 ± 3-fold to 20 ± 3-
fold, in case of the Pdgfra promoter from 4 ± 1-fold to 1-
fold (Figure 2F,G). This suggests thatMyrfmay have a dual
function in oligodendroglial cells. It synergistically supports
Sox10 activity on its oligodendrocyte-specific target genes,
but at the same time inhibits Sox10 function on its OPC-
specific target genes.
Myrf represses OPC-specific Sox10 target genes in primary
oligodendrocytes and inhibits OPC characteristics
To confirm the inhibitory effect of Myrf on the expres-
sion of OPC-specific Sox10 target genes, we transduced
primary rat oligodendroglial cells in culture with a Myrf-
expressing retrovirus. After another two days in culture,
cells underwent fixation. Immunocytochemistry was em-
ployed for GFP to identify transduced cells and for Tgfb2,
Id4 and Wnt7a to monitor their protein levels. Com-
pared to mock-transduced control oligodendroglial cells,
fewer Myrf-transduced cells were positive for Tgfb2, Id4 or
Wnt7a (Figure 3A–D). A comparable reduction in Tgfb2,
Id4 or Wnt7a expressing cells was also observed for cells
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Figure 2. Effects of Myrf on the activity of regulatory regions of OPC-specific and oligodendrocyte-specific target genes of Sox10. (A, B) Localization
and distance of ECRs (open boxes) relative to the TSS (arrow) of the mouse Tgfb2, Id4,Wnt7a,Mag, Aatk andMbp genes. Exons are depicted as black
boxes. In case ofMag, the ECR corresponds to the promoter (prom). (C–J) Luciferase assays in N2a cells transiently transfected with reporter genes under
control of regulatory regions from the Tgfb2 (C), Id4 (D), Wnt7a (E), Cspg4 (F), Pdgfra (G), Mag (H), Aatk (I) and Mbp (J) genes in the absence (–) or
presence of Myrf, Sox10, Sox6 or a combination of Myrf and Sox protein. Reporter gene expression was determined in extracts 48 h after transfection
and effector-dependent activation rates are presented as fold inductions ± SEM with transfections in the absence of effectors arbitrarily set to 1 for each
reporter construct (n= 3–4). Differences were statistically significant as determined by one way Anova with Bonferroni correction (*P≤ 0.05; **P≤ 0.01;
***P ≤ 0.001).
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Figure 3. Effects of ectopicMyrf expression on transcription of target genes, proliferation and differentiation of OPCs. (A) Immunocytochemical detection
of Tgfb2 (red) in primary rat oligodendroglial cells that were transduced with control (ctrl), Myrf or MyrfC expressing retrovirus. Transduced cells
were visualized by virally encoded GFP (green). Tgfb2 and GFP are shown in separate channels and as merge. (B–D) Quantification of the fraction of
transduced oligodendroglial cells that expressed Tgfb2 (B), Id4 (C) or Wnt7a (D). Transduction was with control, Myrf or MyrfC expressing retrovirus
(n = 3). (E) BrdU incorporation (red) of primary oligodendroglial cells transduced with control, Myrf or MyrfC expressing retrovirus and kept under
proliferative conditions. Transduced cells were visualized by virally encoded GFP (green). BrdU and GFP are shown in separate channels and as merge. (F,
G) Quantification of the fraction of retrovirally transduced oligodendroglial cells that had incorporated BrdU (F, n = 3) under proliferative conditions or
expressed Mbp under differentiating conditions (G, n = 4). (H) Immunocytochemical detection of Mbp (red) in primary oligodendroglial cells that were
transduced with control, Myrf or MyrfC expressing retrovirus and kept for 3 days under differentiating conditions. Transduced cells were visualized by
virally encoded GFP (green). Mbp and GFP are shown in separate channels and as merge. Scale bars: 50 m. Differences to controls were statistically
significant as determined by one way Anova with Bonferroni correction (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).
transduced with a virus containing MyrfC (Figure 3A–
D). This MyrfC protein lacks the carboxyterminal third
(Figure 4A) that anchors newly synthesizedMyrf in the ER
membrane (9,10).
The Myrf-induced changes in expression of Tgfb2, Id4
or Wnt7a proteins went along with more general changes
in oligodendroglial properties. When kept under prolifer-
ating conditions, Myrf-transduced oligodendroglial cells
exhibited a lower proliferative capacity than their mock-
transduced counterparts (Figure 3E, F). Under differen-
tiating conditions, Myrf-transduced cells showed a higher
propensity for differentiation. This was not only evident
from an increased percentage of Mbp-expressing cells and
higher Mbp levels per cell. The cells also covered a larger
area and had more processes with a higher degree of ram-
ification and greater portions of membrane sheets (Fig-
ure 3G, H). These morphological changes are character-
istic of differentiating oligodendrocytes and suggest that
Myrf-transduction indeed promotes oligodendrocyte dif-
ferentiation rather than just premature Mbp expression.
Again, transduced cells expressing MyrfC behaved sim-
ilar to those expressing full length Myrf. These results con-
firm thatMyrf has general effects on oligodendroglial prop-
erties by promoting differentiation and inhibiting prolifera-
tion. These effects furthermore appear largely mediated by
the aminoterminal two thirds of the protein.
The influence ofMyrf on Sox10 activity depends on its ability
to trimerize
To understand the mechanism that allows Myrf to support
Sox10 on its oligodendrocyte-specific target genes and at
the same time repress it on its OPC-specific target genes,
we analyzed several Myrf mutants (Figure 4A) for their ef-
fects on Sox10-dependent activation of the regulatory re-
gions from the Mag and Wnt7a genes as representative
oligodendrocyte- and OPC-specific target genes. MyrfC
was able to stimulate Sox10 activity on the Mag regula-
tory region and inhibit Sox10 activity on the Wnt7a reg-
ulatory region arguing that the aminoterminal two thirds
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Figure 4. Structural requirements for Myrf function. (A) Schematic rep-
resentation of the Myrf protein, its functional domains and the mutants
used in the study. Numbers indicate positions of amino acids that define
beginning or end of domains or constructs. P-rich, proline-rich domain;
DBD, DNA binding domain; ICD, intracellular chaperone domain; CC,
coiled coil domain; TM, transmembrane domain. (B, C) Luciferase assays
in N2a cells transiently transfected with reporter genes under control of
theMag promoter (B) orWnt7a regulatory region (C) in the absence (-) or
presence ofMyrf, variousMyrf mutants, Sox10 and combinations thereof.
Reporter gene expressionwas determined in extracts 48 h after transfection
and effector-dependent activation rates are presented as fold inductions ±
SEM with transfections in the absence of effectors arbitrarily set to 1 (n
= 3). Differences were statistically significant as determined by one way
Anova with Bonferroni correction (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).
of Myrf are sufficient for both activities (Figure 4B, C).
In contrast, MyrfDBD, a Myrf mutant further shortened
at its carboxyterminus than MyrfC (Figure 4A) was no
longer capable of synergistically activating the Mag regu-
latory region (Figure 4B). MyrfDBD also failed to repress
the Sox10-dependent activation of the Wnt7a ECR (Fig-
ure 4C). Similar to MyrfC, MyrfDBD contains the com-
plete DNA-binding domain. However, it lacks a functional
ICD that mediates trimerization as well as autoproteolysis
ofMyrf into an aminoterminal nuclear and a carboxytermi-
nal ER-anchored part (9,10). Our results therefore point to
the ICD and its trimerization function as essential for both
the stimulating and repressing activities of Myrf.
DNA-binding of Myrf requires two consensus motifs in a de-
fined distance
From ChIP-Seq experiments, 5′-CTGGYAC-3′ had been
identified as consensus motif for Myrf binding in the
genome (9). To analyze whether DNA binding of Myrf is
a prerequisite for its stimulatory and repressive activities,
we searched for potential binding motifs in the Tgfb2, Id4,
Wnt7a, Aatk, Mag and Mbp regulatory regions. By allow-
ing up to one mismatch, we detected multiple such motifs
in all regulatory regions. There was no obvious difference
in localization of these motifs to each other or to potential
Sox10 binding sites that would clearly distinguish regula-
tory regions with activity in OPCs from regulatory regions
with activity in oligodendrocytes. Thus, bioinformatics ar-
gued for binding ofMyrf to all regulatory regions, but failed
to offer an explanation for the differential response towards
Myrf.
So far, DNA binding characteristics of Myrf have not
been studied biochemically. To better understand its mode
of action, we initiated such an investigation by EMSA using
conditions we recently established to visualizeMyrf binding
toDNA in vitro (25). To optimize our ability to detectMyrf,
we used a MyrfNC variant that consists of DNA-binding
domain, ICD and intervening sequences and thus contains
all regions for proper carboxyterminal processing, trimer-
ization and DNA-binding (Figure 4A).
First, we analyzed whetherMyrf would be able to bind to
an oligonucleotide with a consensus 5′-CTGGCAC-3′ mo-
tif in the center (oligonucleotide (c) in Figure 5A). Contrary
to our expectations from bioinformatic analysis, EMSA
yielded only a very weak complex between Myrf and this
oligonucleotide arguing against high-affinity binding (Fig-
ure 5B). Considering that Myrf forms trimers and that
these trimers contain three DNA-binding domains, we rea-
soned that multiple consensus motifs may be necessary to
permit high-affinity DNA-binding. Therefore, we designed
oligonucleotides with two or three 5′-CTGGCAC-3′ motifs.
The spacing was chosen such that the central nucleotides
of each motif were 10 or 20 bp apart (Figure 5A). As a
consequence, both motifs were separated by one or two
helical turns and thus present on the same side of the
DNA. The two motifs had identical head-to-tail orienta-
tion. An oligonucleotide with two 5′-CTGGCAC-3′ mo-
tifs spaced two helical turns apart again failed to bind sub-
stantial amounts of Myrf (oligonucleotide (c)13(c) in Fig-
ure 5B). In contrast, strong Myrf binding was observed to
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Figure 5. Effect of number, spacing and orientation of consensus motifs on the DNA binding ability of Myrf. (A) Sequence of oligonucleotides containing
one or more consensus motifs for Myrf in different distances and orientations. Consensus motifs are highlighted by gray boxes; motif orientations are
indicated by arrows. (B–E) EMSA with listed oligonucleotides as probes and extracts fromHEK293 cells as protein source. HEK293 cells were transfected
with empty (ctrl), MyrfNC (Myrf) or MyrfDBD (DBD) (see Figure 4A) expression plasmids. Analyzed was the influence of the number of consensus
motifs (B), the requirement for Myrf trimerization (C), consensus motif spacing (D) and orientation (E) as well as a combination of number, spacing and
orientation (F). –, no extract added. The position of the Myrf–DNA complex is marked by an arrowhead.
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Figure 6. Effect of motif variations on DNA binding of Myrf. (A, B) Sequence of oligonucleotides containing two Myrf consensus motifs with single
mismatches in the lateral motif (A) or with a mismatch at position 4 in the lateral motif and additional single mismatches in the central motif (B). (C,
D) EMSA with oligonucleotides containing mismatches in one (C) or both (D) of the Myrf consensus motifs. Extracts from mock- (ctrl) or MyrfNC-
transfected (Myrf) HEK293 cells served as protein source. The position of the Myrf–DNA complex is marked by an arrowhead.
an oligonucleotide that contained the consensus motifs one
helical turn apart (oligonucleotide (c)3(c) in Figure 5B).
The presence of a third motif in head-to-tail orientation
and one helical turn apart did not further increase Myrf
binding (oligonucleotide (c)3(c)3(c) in Figure 5B). We con-
clude from these results, that at least two closely spaced 5′-
CTGGCAC-3′ motifs are required to permit high-affinity
binding and that the binding species is a Myrf trimer. The
latter conclusion was further supported by EMSA with
Myrf DBD. This monomeric Myrf variant failed to bind to
DNA independent of whether oligonucleotides contained
one or two consensus motifs in head-to-tail orientation and
one helical turn apart (Figure 5C).
To further investigate the exact spacing requirements, we
generated a set of oligonucleotides in which we changed the
distance of the two consensus motifs by inserting up to five
additional basepairs between them (Figure 5A).Already the
addition of a single basepair dramatically reduced the abil-
ity of Myrf to bind (oligonucleotide (c)4(c) in Figure 5D).
In fact, Myrf binding remained low on all oligonucleotides
except the one with an insertion of four basepairs (oligonu-
cleotide (c)7(c) in Figure 5D). This insertion changes the
spacing of both motifs from one helical turn to one and
a half turns. We therefore conclude that Myrf binding re-
quires two consensus motifs that are either one helical turn
apart and aligned on the same side of the helix, or one and
a half turns apart on opposite sides.
To look into the effects of motif orientation, we also gen-
erated oligonucleotides with two consensus motifs spaced
one or two helical turns apart and opposite (head-to-head)
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Figure 7. Effect ofmotif variations on transcriptional activity ofMyrf. Reporter gene assays in transiently transfectedN2a cells with dimluc-based reporters
where luciferase is under control of a minimal promoter and Sox10 binding site C/C’. In addition to dimluc (A), several reporter variants were tested, in
which the followingMyrf binding sites were inserted: oligonucleotide (c) (B), oligonucleotide (c)3(c) (C), oligonucleotide (c)7(c) (D), oligonucleotide (c)3(r)
(E) and oligonucleotide (7)3(c) (F). For sequences of oligonucleotides and Myrf binding abilities, see Figures 5 and 6. Transfections were carried out in
the absence (-) or presence of Sox10 and Myrf as effectors. Reporter gene expression was determined in extracts 48 h after transfection and effector-
dependent activation rates are presented as fold inductions ± SEM with transfections in the absence of effectors arbitrarily set to 1 (n = 3–4). Myrf did
not change reporter gene expression substantially on its own (data not shown). Differences were statistically significant as determined by one way Anova
with Bonferroni correction (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).
orientations (Figure 5A). In EMSA, these oligonucleotides
behaved similar to the corresponding oligonucleotides that
contained two consensus sites in identical orientations (Fig-
ure 5D). The one with a spacing of one helical turn between
the two motifs was bound avidly (oligonucleotide (c)3(r) in
Figure 5E), whereas the one with a spacing of two turns
exhibited no substantial binding of Myrf (oligonucleotide
(c)13(r) in Figure 5E). At first approximation, we conclude
that the orientation of motifs relative to each other is of
much less importance than their spacing.
With a better knowledge of the effects of motif orienta-
tion and spacing, we generated additional oligonucleotides
with three consensus motifs in various orientations and
spacings compatible with Myrf binding (Figure 5A) and
compared Myrf binding to these oligonucleotides relative
to the originally tested oligonucleotide where all three mo-
tifs had the same orientation and were spaced one helical
turn apart. In our hands, Myrf bound all tested oligonu-
cleotides equally well independent of orientation or spacing
at one or 1.5 helical turns of the three consensus sites (Fig-
ure 5F). This reaffirms our previous conclusion that a third
consensus motif has no further effect on high-affinity Myrf
binding.
To be able to predict genomic Myrf binding sites we next
analyzed the impact of mismatches in one consensus mo-
tif on the ability of Myrf to bind. For that purpose, we used
the oligonucleotide as template that contained twomotifs in
head-to-tail orientation spaced one helical turn apart, and
generated a series in which single positions were exchanged
in the lateral motif (Figure 6A). Changes were such that a
purine was converted into the non-complementary pyrim-
idine and vice versa. In EMSA, most of the introduced
mutations substantially reduced Myrf binding, but did not
abolish it (Figure 6C). The impact on Myrf binding was
particularly dramatic for the mutation introduced at posi-
tion 7 (oligonucleotide (7)3(c) in Figure 6C) and less severe
than most mutations for the change at position 1 (oligonu-
cleotide (1)3(c) in Figure 6C). The mutation introduced at
position 4 had no major effect on Myrf binding (oligonu-
cleotide (4)3(c) in Figure 6C). We therefore conclude from
these studies that a single mismatch in one of the two bind-
ing motifs may be compatible withMyrf binding depending
on the exact nature of the altered basepair.
We next askedwhether it would even be possible that both
binding motifs contain a mismatch. For this set of experi-
ments, we started out with the mutant oligonucleotide from
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Figure 8. Identification of functional Myrf binding sites in the regulatory regions of Sox10 target genes. (A) Summary of potential Myrf binding sites with
two or more consensus motifs in the regulatory regions of the Tgfb2, Id4, Wnt7a, Mag, Aatk and Mbp genes in naturally occurring (top) and mutated
version (bottom). For theTgfb2ECR, one of themany single consensusmotifs is additionally shown. Consensusmotifs are highlighted by gray boxes; motif
orientations are indicated by arrows. (B–D) EMSAwith oligonucleotides containing potential Myrf binding sites in OPC-specific (B) and oligodendrocyte-
specific (C) Sox10 target genes or mutant versions thereof (D). Extracts frommock- (ctrl) or MyrfNC-transfected (Myrf) HEK293 cells served as protein
source. The position of Myrf-DNA complexes is marked by an arrowhead.
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Figure 9. Functional and physical interaction between Myrf and Sox10. (A–D) Luciferase assays in N2a cells transiently transfected with reporter genes
under control of regulatory regions from the Mag (A), Aatk (B, C) or Mbp (D) genes, in which Myrf binding sites were destroyed by mutation. (E)
Luciferase assays in N2a cells transiently transfected with a reporter gene under control of theWnt7a regulatory region in combination with Myrf binding
site (c)3(c). Transfections were carried out in the absence (–) or presence of Sox10 and Myrf as effectors. Reporter gene expression was determined in
extracts 48 h after transfection and effector-dependent activation rates are presented as fold inductions ± SEM with transfections in the absence of
effectors arbitrarily set to 1 (n = 3–4). (F) ChIP on formaldehyde-crosslinked and sheared chromatin from primary rat oligodendroglial cells cultured
for three days under differentiating conditions using rabbit pre-immune (PI, black bars), anti-Sox10 (Sox10, light gray bars), and anti-Myrf (Myrf,
dark gray bars) antisera. Amounts of immunoprecipitated chromatin were determined for the regulatory regions of the Tgfb2, Id4, Wnt7a, Mag, Aatk
and Mbp genes and a negative control region (NCtrl) by quantitative PCR, and enrichments relative to input were calculated after normalization. Four
independent immunoprecipitations were performed and the highest value of each experiment was set to 1. Presentation is as relative enrichment with
mean values ± SEM. Differences were statistically significant as determined by two-tailed Student’s t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (G)
Co-immunoprecipitation of myc-tagged MyrfC with antiserum directed against Sox10 (Sox10) from HEK293 cell extracts that either contained Sox10
only or a combination of Sox10 andMyrfC. The upperWestern blot was incubated with antibodies specific for the myc epitope, the lower with antibodies
specific for Sox10. (H) Co-immunoprecipitation of Sox10 with antiserum directed against the myc epitope (myc) from HEK293 cell extracts that either
contained Sox10 only or a combination of Sox10 and myc-tagged MyrfC. The upper Western blot was incubated with antibodies specific for Sox10
(Sox10), the lower with antibodies specific for the myc epitope. (I) GST-pulldown assays with myc-tagged MyrfC containing HEK293 extract (input)
using bacterially expressed GST (-) or GST fused to specific domains of Sox10 (27), bound to glutathione sepharose beads as baits. The following Sox10
domains were used: DIM/HMG, dimerization and HMG-domain; K2, central protein-protein interaction domain; TA, transactivation domain. Bound
MyrfC was visualized by Western blot using specific antibodies. Input corresponds to 1/20 of the amount of extract used in the assay. Numbers on the
right side of western blots represent molecular weights of co-electrophoresed size markers. (J) Summary of proposed mode ofMyrf action on OPC-specific
and oligodendrocytes-specific target genes of Sox10.
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the previous series that contained a mismatch at position 4
of the lateral motif, and now introduced additional muta-
tions at single positions in the central motif employing the
same principles as previously used in the study of the lat-
eral motif (Figure 6B). As evident from EMSA, most in-
troduced mutations severely affected Myrf binding (Figure
6D). However, some oligonucleotides retained a substantial
amount of Myrf binding. Again changes at positions 1 and
4 appeared to be the least harmful (oligonucleotides (4)3(1)
and (4)3(4) in Figure 6D). Our results therefore argue that
Myrf may bind to two closely spaced motifs even if both do
not fully conform to the consensus and have a mismatch.
Our results also suggest that changes at positions 4 and 1
are least detrimental to Myrf binding, whereas changes at
position 7 are most. However, these latter conclusions have
to be taken with caution as we have introduced only one
out of three possible changes at a particular position. Ad-
ditionally, our binding motifs were embedded in a defined
sequence environment. Both the exact nature of the intro-
duced change and the surrounding sequences may have an
impact on Myrf binding that we cannot predict from our
studies.
Transcriptional activation by Myrf requires two closely
spaced consensus motifs
To analyze how the determined DNA-binding characteris-
tics influence the transcriptional activity of Myrf, we gen-
erated a series of artificial reporter gene constructs. All of
them contained a luciferase gene under control of aminimal
promoter and a well-characterized dimeric Sox10 binding
site (C/C’, see (23). As expected, this dimluc reporter con-
struct was robustly activated by Sox10 in transiently trans-
fected N2a cells (Figure 7A). When Myrf was addition-
ally present in N2a cells, the Sox10-dependent activation
decreased significantly. Into this reporter gene construct,
we inserted several representative oligonucleotides from our
binding studies. The integration of a single Myrf consensus
motif in the luciferase reporter did not alter the behaviour
of the construct. Again it was strongly activated in tran-
siently transfected cells by Sox10 and much of the activity
was lost when Myrf was additionally present (Figure 7B).
However, when the fully functionalMyrf binding site (c)3(c)
was present that consisted of two consensus motifs at a dis-
tance of one helical turn, Sox10-dependent activation was
increased in the presence ofMyrf (Figure 7C). The same co-
activation was observed when the consensusmotifs were 1.5
helical turns apart, or in head-to-head instead of head-to-
tail arrangement (Figure 7D, E). In contrast co-activation
was lost when one of the two motifs contained a mismatch
at position 7 (Figure 7F). Instead we observed a substantial
reduction of the Sox10-dependent activation by Myrf with
this reporter. These results argue that high-affinity binding
of Myrf to a Sox10-responsive regulatory region likely cor-
relates with co-activation.
Myrf binds to oligodendrocyte-specific, but not to OPC-
specific Sox10 target genes
After better understanding the DNA binding properties of
Myrf, we revisited the regulatory regions of the Tgfb2, Id4,
Wnt7a, Mag, Aatk and Mbp genes and searched for the
presence of two potential binding motifs spaced 1–1.5 he-
lical turns apart and with less than three mismatches to the
consensus in total. This analysis revealed the presence of
one potential Myrf binding site in the regulatory regions of
the Tgfb2,Wnt7a andMag genes and two potential ones in
the regulatory regions of the Aatk and Mbp genes (Figure
8A).
Potential binding sites were analyzed as oligonucleotides
in EMSA for their ability to bind Myrf. An oligonucleotide
with a single consensus motif from the Tgfb2 regulatory
region was also included in the EMSA as a representative
of the many single motifs in the various regulatory regions
(Tgfb2 S1 in Figure 8A). However, no binding was observed
to this single motif or any of the potential binding sites
in the OPC-specific ECRs (Figure 8B). In contrast, strong
binding of Myrf was observed to the Mag S1, the Aatk S1
and the Mbp S1 sites (Figure 8C). Weaker binding was de-
tected to Aatk S2, followed by Mbp S2. Next, we intro-
duced mutations into the Mag S1, Mbp S1, Aatk S1 and
Aatk S2 sites (Figure 8A). These mutations abolished Myrf
binding, thus confirming that binding sites were correctly
determined (Figure 8D).
When the same mutations were introduced into the con-
text of theMag, Aatk andMbp regulatory regions, these re-
gions retained their responsiveness to Sox10 when reporter
gene assays were performed in transiently transfected N2a
cells (Figure 9A–D).However, theywere no longer synergis-
tically activated by Myrf (compare Figure 9A–D to Figure
2H–J). Instead, Myrf now decreased the Sox10-dependent
activation of the mutantMag, Aatk andMbp regulatory re-
gions. This argues that synergistic activation of target genes
by Sox10 and Myrf requires high-affinity binding of both
proteins to the corresponding regulatory regions. In the ab-
sence of a binding site, Myrf impairs Sox10-dependent ac-
tivation.
Myrf binding sites were not detected in the three analyzed
regulatory regions from OPC-specific Sox10 target genes.
When we artificially inserted such a binding site in immedi-
ate proximity to the Wnt7a regulatory region in a reporter
plasmid, its behaviour changed dramatically (compare Fig-
ure 9E to Figure 2E). Myrf no longer repressed the Sox10-
dependent activation of the Wnt7a ECR. Instead we ob-
tained a synergistic activation by Sox10 and Myrf. We con-
clude that Myrf represses the activity of Sox10 on its OPC-
specific target genes without binding to the corresponding
regulatory regions.
To further confirm this conclusion, we analyzed in vivo
binding of Sox10 and Myrf by performing ChIP on cul-
tured oligodendroglial cells. After three days in differenti-
ating conditions, cultures contain OPCs as well as oligo-
dendrocytes. Using these cultures, Tgfb2, Id4 and Wnt7a
regulatory regions were enriched in chromatin precipitated
with antibodies directed against Sox10 (Figure 9F). We as-
sume that the precipitated chromatin stems from the OPCs
present in the culture. No enrichment was obtained for any
of the three regions after precipitation with antibodies di-
rected against Myrf. ChIP therefore confirms that Myrf
binding does not occur on the Tgfb2, Id4 andWnt7a regu-
latory regions in vivo. In contrast,Mag,Aatk andMbp reg-
ulatory regions were equally enriched in chromatin precip-
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itated with antibodies directed against Sox10 and antibod-
ies directed against Myrf. (Figure 9F). Enriched chromatin
likely stems from the fraction of differentiating oligoden-
drocytes in the culture. In linewith our findings, overlapping
peaks were also detected in published ChIP-Seq studies for
Sox10 and Myrf in the Aatk and Mbp regulatory regions
(9,20). For theMag promoter only Myrf binding had been
detected. Considering the Sox10 responsiveness of theMag
promoter and our ChIP results, we hypothesize that Sox10
binds as well and has beenmissed in the genome-wide study.
Myrf inhibits Sox10 activity by sequestration
In the absence of binding sites forMyrf in Sox10-responsive
regulatory regions,Myrfmay physically interact with Sox10
and thereby prevent Sox10 from binding and activat-
ing these regions. To look into this possibility, we per-
formed co-immunoprecipitation experiments. Previous co-
immunoprecipitations had failed to detect an interaction
between the aminoterminal part of Myrf and Sox10 (8).
However, these experiments had used Myrf fragments that
lacked the capability to trimerize.
By using HEK293 extracts that contained Sox10 and a
myc-tagged version of the trimer-forming MyrfC protein
(Figure 4A) we were able to precipitateMyrfCwith Sox10
antibodies (Figure 9G) and Sox10 with myc-tag antibod-
ies (Figure 9H). In GST pulldown experiments, MyrfC
furthermore bound to a bacterially produced protein frag-
ment spanning dimerization and DNA-binding domain of
Sox10 (Figure 9I). No binding was detected to other known
functional domains of Sox10 such as the centrally located
protein-protein interaction domain K2 and the carboxyter-
minal transactivation domain. These results suggest that the
aminoterminal two thirds of Myrf physically interact with
Sox10 even in the absence of DNA-binding.
DISCUSSION
Myrf is a central transcriptional regulator of the terminal
differentiation process in oligodendrocytes and essentially
required for CNS myelination (7). To fulfil its function,
Myrf binds to regulatory regions of terminal differentia-
tion and myelination genes and activates their expression
(9). In this function, it cooperates with Sox10, another im-
portant transcription factor with multiple roles during sev-
eral phases of oligodendroglial development (8,11,36).
Interestingly, Myrf induction precedes the induction of
terminal differentiation, and reports of reduced survival
of Myrf-deficient oligodendroglial cells during this short
period suggest that Myrf is already required in oligoden-
droglial cells before the onset of terminal differentiation (7).
Here, we present data that lead us to propose that during
this period Myrf inhibits the activity of Sox10 on its target
genes in OPCs and thereby helps to redirect Sox10 to a new
set of target geneswhich it then synergistically activates with
Myrf during terminal differentiation. We therefore suggest
that Myrf acts as a modulatory switch for the activity of
Sox10 (Figure 9J).
To unravel the underlying mechanism of this switch func-
tion, we first had to identify genes that are regulated by
Sox10 in OPCs and the corresponding regulatory regions
that mediate Sox10 activity. Additionally, we had to ob-
tain a better understanding of the DNA-binding character-
istics ofMyrf. Bioinformatic analyses of ChIP-Seq data had
determined that regions occupied by Myrf throughout the
genome are enriched for 5′-CTGGYAC-3′ and had identi-
fied this heptameric consensus as binding motif for Myrf
(9).
Our current studies, however, show that one consensus
motif does not permit strong binding of Myrf. At least two
motifs are required. This finding makes sense as Myrf is
known to assemble into homotrimers in the ER-membrane
before autoproteolysis and nuclear translocation of the
aminoterminal part (9,10). Homotrimers of the aminoter-
minal part have been defined as the transcriptionally ac-
tive species (25,37) and they possess three identical DNA-
binding domains. We furthermore show in this study that
the affinity of a single DNA-binding domain to consen-
sus motifs is low. Therefore, our results indicate that two
of the DNA-binding domains in the Myrf trimer have to
contact consensus motifs to permit strong binding toDNA.
Interestingly, we did not detect a further increase in bind-
ing strength when three consensus motifs were present. The
reason for this is currently unknown. It may indicate that a
DNA-binding domain in one of the Myrf subunits remains
available for other functions, such as protein–protein inter-
actions.
In accord with the well-defined, structurally tight ar-
rangement of the DNA-binding domains in a trimer (38),
binding motifs have to occur in a clearly defined distance to
each other. We found that the two binding motifs had to be
1 or 1.5 helical turns apart. In contrast, binding site orien-
tation was quite flexible with both head-to-tail and head-to-
head arrangements equally functional. Similarly, we found
that at least some mismatches in both binding motifs are
compatible with continued high-affinity binding.
By applying this newly acquired knowledge to regulatory
regions that are both responsive to Sox10 and Myrf, we
were able to define two groups. One group of regulatory re-
gions contained strong binding sites for Myrf and Sox10,
mediated synergistic activation by both transcription fac-
tors and belonged to genes activated during terminal differ-
entiation in oligodendrocytes. The other contained Sox10
binding sites, but lacked Myrf binding sites. These regula-
tory regions exhibited reduced Sox10-responsiveness in the
presence of Myrf and segregated to genes that are activated
by Sox10 in OPCs and downregulated upon terminal dif-
ferentiation. This clearly argues that joint binding of Sox10
and Myrf is a prerequisite for synergistic activation. One
possibility is that joint binding is cooperative and that co-
operative binding triggers synergistic activation. Unfortu-
nately, we cannot test this hypothesis for technical reasons.
Myrf requires the use of polydIdC as unspecific competitor
and is highly sensitive to polydGdC, whereas the opposite is
true for Sox10. Therefore, we cannot perform EMSA with
both proteins.
Myrf-dependent impairment of Sox10-responsiveness
appears to follow a different mechanism. In this respect, it
is important to note that the aminoterminal, homotrimer-
izing two thirds ofMyrf physically interact with Sox10 even
in the absence of DNA. Therefore it seems plausible that
Myrf exerts its inhibitory role on the Sox10-dependent acti-
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vation of regulatory regions from OPC genes by sequester-
ing Sox10 away or redirecting it to regulatory regions that
contain Sox10 and Myrf sites. This appears physiologically
meaningful as it allows Sox10 to switch in a temporally con-
trolledmanner fromone set of target genes to a different one
as a prerequisite for proper lineage progression and success-
ful terminal differentiation.
With this study, the regulatory relationship between
Sox10 and Myrf has gained additional complexity. First,
Sox10 induces Myrf which redirects Sox10 activity away
from its OPC-specific target genes and then cooperates with
Sox10 to activate a new set of genes required during termi-
nal differentiation and myelination.
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